Ballı Turhan, F. N. Et Al. 2022. Can dual ART mitigate the risk of potential drug-drug interactions among people living with human immunodeficiency virus under stable ART?. 50th ESCP Symposium on Clinical Pharmacy , (Praha, Czech Republic), 1547-1548.

Ballı Turhan, F. N., Kara, E., İnkaya, A. Ç., Demirkan, S. K., & Ünal, S., (2022). Can dual ART mitigate the risk of potential drug-drug interactions among people living with human immunodeficiency virus under stable ART? . 50th ESCP Symposium on Clinical Pharmacy (pp.1547-1548). Praha, Czech Republic

Ballı Turhan, FATMA Et Al. "Can dual ART mitigate the risk of potential drug-drug interactions among people living with human immunodeficiency virus under stable ART?," 50th ESCP Symposium on Clinical Pharmacy, Praha, Czech Republic, 2022

Ballı Turhan, FATMA N. Et Al. "Can dual ART mitigate the risk of potential drug-drug interactions among people living with human immunodeficiency virus under stable ART?." 50th ESCP Symposium on Clinical Pharmacy , Praha, Czech Republic, pp.1547-1548, 2022

Ballı Turhan, F. N. Et Al. (2022) . "Can dual ART mitigate the risk of potential drug-drug interactions among people living with human immunodeficiency virus under stable ART?." 50th ESCP Symposium on Clinical Pharmacy , Praha, Czech Republic, pp.1547-1548.

@conferencepaper{conferencepaper, author={FATMA NİSA BALLI TURHAN Et Al. }, title={Can dual ART mitigate the risk of potential drug-drug interactions among people living with human immunodeficiency virus under stable ART?}, congress name={50th ESCP Symposium on Clinical Pharmacy}, city={Praha}, country={Czech Republic}, year={2022}, pages={1547-1548} }